Dashboard
Manage Tickers

SGMO


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
08/22/2024 13:03:50

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

sangamo-therapeutics-expects-fy24-gaap-basis-total-operating-expenses-of-approximately-150m---170m
Sangamo Therapeutics Expects FY24 GAAP Bas...
08/06/2024 21:57:50

It expect non-GAAP total operating expenses, excluding estimated non-cash stock-based compensation expense of approximately $13...

sangamo-therapeutics-q2-2024-gaap-eps-018-misses-016-estimate-sales-356000k-miss-8260m-estimate
Sangamo Therapeutics Q2 2024 GAAP EPS $(0....
08/06/2024 21:29:16

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate o...

why-sangamo-therapeutics-stock-is-soaring
Why Sangamo Therapeutics Stock Is Soaring
08/06/2024 17:39:48

Sangamo Therapeutics shares are trading higher Tuesday after the company announced it has entered into a license agreement with...

sangamo-enters-license-agreement-with-genentech-to-develop-intravenously-administered-genomic-medicines-for-neurodegenerative-diseases-co-expected-to-receive-50m-in-near-term-upfront-license-fees-and-is-eligible-for-up-to-19b-in-milestones
Sangamo Enters License Agreement With Gene...
08/06/2024 12:06:59

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
07/31/2024 12:20:40

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

why-saia-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Saia Shares Are Trading Lower? Here Ar...
07/26/2024 17:25:58

peering-into-sangamo-therapeuticss-recent-short-interest
Peering Into Sangamo Therapeutics's Recent...
07/25/2024 20:15:13

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
07/24/2024 19:22:45

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

crude-oil-gains-1-att-shares-rise-after-q2-earnings
Crude Oil Gains 1%; AT&T Shares Rise After...
07/24/2024 18:37:16

why-general-dynamics-shares-are-trading-lower-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why General Dynamics Shares Are Trading Lo...
07/24/2024 17:26:11

dow-tumbles-300-points-tesla-shares-plunge-after-q2-results
Dow Tumbles 300 Points; Tesla Shares Plung...
07/24/2024 16:30:09

sangamo-stock-spikes-as-pfizer-partnership-meets-goal-in-late-stage-study
Sangamo Stock Spikes As Pfizer Partnership...
07/24/2024 16:10:52

Pfizer's Phase 3 AFFINE study of giroctocogene fitelparvovec gene therapy for hemophilia A meets key endpoints, showing a s...

sangamo-therapeutics-shares-resume-trade
Sangamo Therapeutics Shares Resume Trade
07/24/2024 13:43:14

sangamo-therapeutics-shares-halted-on-circuit-breaker-to-the-downside-stock-now-up-695
Sangamo Therapeutics Shares Halted On Circ...
07/24/2024 13:37:53

Core News & Articles
Sangamo Therapeutics Announces Pfizer's Ph...
07/24/2024 12:28:17

critical-insights-from-sangamo-therapeutics-analyst-ratings-what-you-need-to-know
Critical Insights From Sangamo Therapeutic...
05/15/2024 15:01:53

hc-wainwright--co-reiterates-buy-on-sangamo-therapeutics-maintains-5-price-target
HC Wainwright & Co. Reiterates Buy on Sang...
05/15/2024 14:34:28

HC Wainwright & Co. analyst Patrick Trucchio reiterates Sangamo Therapeutics (NASDAQ:SGMO) with a Buy and maintains $5 p...

sangamo-therapeutics-q1-2024-gaap-eps-027-misses-022-estimate-sales-481000k-miss-6654m-estimate
Sangamo Therapeutics Q1 2024 GAAP EPS $(0....
05/09/2024 20:30:15

Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate o...

sangamo-therapeutics-presents-modular-integrase-technology-engineered-to-enable-large-scale-genome-editing
Sangamo Therapeutics Presents Modular Inte...
05/09/2024 12:45:44

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION